The problems of anticoagulant control. 1. Drug interactions.
D000925:Anticoagulants / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000627:therapeutic use*; D001463:Barbiturates / Q000009:adverse effects; D001665:Binding Sites; D004357:Drug Synergism; D004790:Enzyme Induction; D004791:Enzyme Inhibitors; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008099:Liver / Q000201:enzymology; D008297:Male; D011485:Protein Binding; D014280:Triglycerides / Q000097:blood; D014812:Vitamin K / Q000097:blood / Q000378:metabolism; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D001463:Barbiturates; D004791:Enzyme Inhibitors; D014280:Triglycerides; D014812:Vitamin K; D014859:Warfarin